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Background. Intra-articular infections can rapidly lead to osteoarthritic degradation. The aim of this clinical biomarker analysis was 
to investigate the influence of inflammation on cartilage destruction and metabolism. Methods. Patients with acute joint infections 
epidemiology and disease severity were correlated with levels of cytokines with known roles in cartilage turnover and degradation. 
 
synovial IL-1� levels were associated with increased i tra-articular collagen type II cleavage pr ducts (C2C) indicating cartilage 
 
degradation. Joints with preinfectious lesions had higher C2C levels. Intra-articular inflammation led to increased concentrations 
of typical cartilage metabolites as bFGF, BMP-2, and BMP-7. Infections with Staphylococcus species induced higher IL-1 expression 
but less cartilage destruction than other bacteria. Conclusion. Articular infections have bacteria-specific implications on cartilage 
metabolism. Collagen type II cleavage products reliably mark destruction, which is associated with upregulation of typical cartilage 
turnover cytokines. This trial is registered with DRKS00003536, MISSinG. 
 
 
 
1. Introduction bacterial toxins on chondrocytes causing their death have 
function and cause pain. Furthermore, they can lead to long- by the NF-� pathway in septic arthritis, an example for Intra-articular infections are deleterious for near-term joint 
 
term osteoarthritic degradation, suggesting an association 
of acute inflammation and a catabolic cartilage metabolism. 
The regulatory mechanisms behind this are not yet fully 
understood. Until now, most data available is about the 
association of chronic inflammatory diseases as rheuma- 
toid arthritis and cartilage degradation, describing causal 
, IL-6, 
or death receptor 3 [1]. Furthermore, direct toxic effects of 
been described [2]. Moreover, toll-like receptors (TLR) do 
exhibit both proinflammatory and catabolic effects mediated 
B 
overlapping functions in regulatory pathways [3]. The inter- 
actions between mediators upregulated during infection and 
cartilage metabolism need to be clarified in order to develop 
effective interventional strategies. Therefore, the aim of this 
clinical trial was to correlate parameters defining the sever- 
ity of inflammation with proteins characterizing cartilage 
degradation and metabolism. We hypothesized that there is 
a statistically significant association between certain clinical 
) excluding the incidence of sepsis. Additionally, intra-articular IL-1 levels correlated with inflammatory serum parameters 
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protocol  violations  (�   =   3 
fulminant lung embolism (� =  
≥ 
Mann and Whitney. Multiple compariso
�-test  according  to
 
the average BMI was 27.8 ± 7, and the ratio of female and 
± 
the  Spearman  coefficient  (� 
mined by 
calculating
)  for the 
�-test according to 
� < 0.05 
� = 57 
2.4. ELISA and Protein Content. Cytokine and protein con- 
population, patients with exclusive knee infections  were 
protein- [BMP-] 2 and BMP-7, and collagen type 2 cleavage 
[C2C]) in synovial joint fluids from acutely infected knee 
the ratio of female and male patients was 73.7%/26.3% (no 
statistically significant difference between the analysis groups 
 
symptoms, synovial expression of inflammatory mediators, 
cartilage degradation, and cytokines with known importance 
in cartilage metabolism. 
2. Material and Methods 
2.1. Clinical Trial. The trial was registered (MISSinG, 
DRKS00003536) and approved by the Ethics Board of the 
University of Freiburg (AN-EK-FRBRG-50/11). All patients 
participating in this study provided their written consent. 
As already described in previous publications [4, 5], a 
consecutive series of 75 patients treated between April 2011 
and November 2012, presenting the clinical symptoms of bac- 
terial joint infection, were recruited for the prospective col- 
lection of joint fluid. All patients suffered from pain, swelling, 
effusion, and elevated inflammatory serological parameters 
(e.g., C-reactive protein). Effusions from 76 affected joints 
were included in the analysis. Infections of knee (75%), hip 
(6.6%), ankle (1.3%), and shoulder (17.1%) were included. 
Four other patients had to be excluded because of storage- 
) or sudden death because of 
, no written consent). 
2.2. Sample Storage. Effusions were obtained within the first 
24 hours after diagnosis during arthroscopy or preoperative 
puncture and immediately frozen. Specimens were stored in 
liquid nitrogen until analysis. 
joints or coculture supernatants were analyzed by ELISA 
(RnD, Minneapolis, MN, USA, and BioSource Deutschland 
GmbH, Solingen, Germany) according to the manufacturers’ 
instructions. The Nitrotyrosine ELISA Kit was purchased 
from Abcam (Cambridge, UK). Briefly, this assay employs 
the quantitative sandwich enzyme immunoassay technique. 
The microplate was precoated with a specific monoclonal 
antibody. Supernatants were applied to the wells and, after 
washing, an HRP-conjugated specific antibody was added 
to the wells. Following the next wash, color development 
was proportional to the protein concentration and calculated 
by comparison with a standard. A colorimetric method was 
applied to quantify total protein amount in the lavage fluids. 
The bicinchoninic acid (BCA) assay was available in kit form 
from Pierce (Rockford, IL, USA) and used according to the 
manufacturer’s instructions [4]. All data from the analyzed 
cytokines and proteins are reported as relative expression to 
the total protein content. Statistical calculations were based 
on these values. 
 
2.5. Data Analysis and Statistics. Concentrations of proteins 
and cytokines determined by the specific ELISAs and the 
BCA assay were calculated according to the manufactur- 
ers’ instructions (RnD, Minneapolis, MN, USA; Thermo 
Scientific, Rockford, IL, USA), creating a standard curve 
and reducing data using a four-parameter logistic  (4-PL) 
nosis and puncture), sex (male/female), body mass index as mean ±  andard error of the mean. Regarding the scores 
2.3. Analyzed Parameters. Age (time point of index diag- 
(BMI), and smoking habits (yes/no) were the epidemiological 
parameters characterizing the patients. For description of 
the septic constellation the following serum values were 
recorded: initial (time point of diagnosis and puncture), 
maximal and final (time point demission) leucocyte counts, 
and C-reactive protein (CRP). Furthermore, the degree of 
systemic inflammation was evaluated using the following 
parameters: necessity for an intensive care treatment, doc- 
umented diagnosis of sepsis (fulfilment of clinical sepsis 
criteria), fulfilment of clinical empyema criteria (synovitis 
grad 2 [6], detection of intra-articular bacteria, and clinical 
necessity of recurrent lavage), and necessity of in-hospital 
treatment. The comorbidity was assessed using the ASA clas- 
sification (physical status according to the American Society 
of Anesthesiologists). Furthermore, the preinfectious joint 
damage was recorded, which was defined as any articular 
lesion including osteoarthritis. The evaluation of the Kellgren 
Lawrence Score [7] was based on conventional X-rays and 
done by 3 independent orthopedic surgeons, resulting in 
a consensus decision. 81% of isolated bacteria belonged to 
Staphylococcus species; in the subgroup of patients with knee 
infections, the portion of isolated Staphylococcus species 
increased to 86%. 
centrations (interleukin- [IL-] 1�, IL-10, aggrecan  [ACAN], 
 
 
curve fit by using GraphPad Prism 5 software (GraphPad 
Software, Inc., La Jolla, CA, USA). All values were expressed 
st 
and all numerical values, statistical significance was tested 
nonparametrically primarily using  the 
ns were calculated 
using a post hoc statistics based on the 
Kruskall-Wallis. Correlations were deter 
predominantly not 
normally distributed values. A cluster analysis with a simple 
agglomeration method was used for grouping values of regis- 
tered cases on the basis of minimal distances between group 
members. This in combination with a percentile analysis or 
known boarders of values (leucocyte counts and CRP) was 
used to group values. Incidences were compared using the chi 
square test. Statistical significance was defined as . 
 
3. Results 
3.1. Characterization of Included Patients and Grouping. 75 
patients with 76 articular infections were included in a 
prospective clinical trial. The average age was 59.7   2.5 years, 
0. 
male patients was 67.1%/32.9%. The distribution of the ASA 
classification, characterizing the patient’s comorbidity, was 
as follows: group 1: 26.3%, group 2: 27.6%, group 3: 42.1%, 
and group 4: 3.9%. In order to gain a more homogenous 
separately analyzed ( ). The averag age of thi  group
 
was 57.2 ± ± 
basic fibroblast growth factor [bFGF], bone morphogenetic 
3.1 years, the average BMI was 27.5 0.9, and 
Mediators of Inflammation 3 
 
osteoarthritis; in-hospital treatment: the difference to an outpatient treatment (< or ≥0.005, � -test; ICU: intensive care unit, n.s.: not 
� 
2
 
� 
� � � 
�  
� 
� 
synovial IL-1� levels in all patients and in the subgroup 
criteria, the majority had synovial IL-1� levels above the 
� 
CRP level or the synovial IL-1� 
� 
� 
� 
also be shown for the leucocyte count maximum (� = 
0.41,
� = 0.002 poin
 
� = 0.45 � =  0.0005 
and C2C levels (� = 0.34, � = 0.002) with initial serum 
� = 0.30 � = 0.006 
the IL-1� 
 
Table 1: The overview shows the relative expression of IL-1 in relation to clinical parameters. ICU: necessity of intensive care treatment; 
sepsis: fulfilment of clinical sepsis criteria; empyema: fulfilment of clinical empyema criteria; preinfectious joint damage: any lesion including 
significant). 
Symptom Group (yes/no) High IL-1� 
 
 
—yes (%) High IL-1 �—no (%) � 
ICU All 22/54 59.1 29.6 0.008 
Knees 16/41 56.3 29.3 0.029 
Sepsis All 12/64 58.3 34.4 n.s. 
 
 
 
 
 
 
for each item). The distribution of the ASA classification, 
characterizing the patient’s comorbidity, was as follows: group 
1: 29.8%, group 2: 28.1%, group 3: 38.6%, and group 4: 
3.5%. All included patients survived, and all infections were 
successfully treated; two times an arthrodesis was necessary. 
 
 
 
 
 
 
Table 2: Association of relative intra-articular IL-1 levels with 
systemic inflammatory parameters (n.s.: not significant). 
Spearman 
Initial leucocyte count All 71 0.29 0.007 
3.2. Synovial IL-1� evels in relation to Clinical Parameters Knees 54 0.26 0.031 
L 
Characterizing the Severity of Infection. Based on a cluster 
analysis, the intra-articular IL-1 levels were regarded as 
increased when the relative expression was higher than 0.005. 
This correlated with the median. The necessity of intensive 
care or an in-hospital treatment was associated with increased 
of septic knee arthritis. In contrast, in case of a clinically 
documented sepsis, intra-articular IL-1 concentrations were 
not elevated. If the patients fulfilled the clinical empyema 
median. Furthermore, a preinfectious joint damage, which 
was defined as any lesion including osteoarthritis, predis- 
posed to higher intra-articular IL-1 concentrations indicat- 
ing a higher degree of inflammation. Data is summarized 
in Table 1. The comorbidity did not influence the degree 
of inflammatory response; there was no correlation of any 
concentrations with the ASA 
classification, and the comorbidity was equally distributed in 
clusters in both all and knee infections. 
 
3.3. Association of Relative Intra-Articular IL-1 Levels with 
Systemic Inflammatory Parameters. To describe the associ- 
ation of joint inflammation and the systemic inflammatory 
reaction, serum and blood levels of C-reactive protein (CRP) 
and leucocyte counts were correlated with synovial IL-1 
levels. The course of septic arthritis was characterized using 
the initial, the maximal, and the final (discharge) systemic 
values. There was no association with the assessments at 
the time point of discharge, which was expected, because 
the inflammation was successfully treated. However, both 
initial and maximal CRP serum concentrations and leucocyte 
counts correlated with intra-articular IL-1 concentrations. 
Data is summarized in Table 2. Nitrotyrosine (NO-Tyr) is a 
 
 
 
 
 
 
 
Knees 
 
known marker of inflammation and NO production, which 
is also known to be associated with cartilage destruction [8]. 
Therefore, we have included an analysis of this marker in 
the study. NO-Tyr failed to show any correlation to clinical, 
serological, or other secretory inflammatory markers. 
 
3.4. Characterizing Cartilage Degradation in Septic Arthritis. 
Degradation of cartilage is characterized by the release of 
extracellular matrix products as collagen (collagen type 2 
cleavage—C2C) or aggrecan. There was a statistically signif- 
icant correlation of synovial aggrecan ( , ) 
leucocyte counts in all patients. In the subgroup of knee 
infections only correlations with C2C concentrations reached 
statistical significance ( , ), which could 
). Increased serum leucocytes at the time   t 
of diagnosis were also associated with higher C2C-levels. 
This association reached statistical significance analyzing all 
patients and the subgroup of knee infections. Reported are 
the C2C levels relative to the total protein content (Figure 1). 
Knees 8/49 50.0 34.7 n.s. 
Empyema All 47/29 51.1 17.2 0.0016 
Knees 34/23 47.1 21.7 0.025 
Preinfectious joint damage All 50/26 48.0 19.2 0.007 
Knees 37/20 43.2 25.0 n.s. 
In-hospital treatment All 69/7 42.0 0.0 0.014 
Knees 51/6 41.2 0.0 0.024 
 
Initial CRP All 71 0.29 0.007 
Knees 54 0.23 0.049 
Maximal leucocyte count All 
  Knees  
Maximal CRP All 
61 
47  
61 
0.28 
—  
0.30 
0.014 
n.s. 
0.010 
Knees 47 — n.s. 
Discharge leucocyte count All 61 — n.s. 
Knees 47 — n.s. 
Discharge CRP All 61 — n.s. 
   47 — n.s. 
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Figure 1: Increased serum leucocytes at time point of diagnosis 
were associated with higher collagen type 2 cleavage levels (C2C), 
analyzing all patients and the subgroup of knee infections. Reported 
are the C2C levels relative to the total protein content. 
progress of osteoarthritis, was associated with enhanced collagen 
type 2 cleavage levels (C2C), defining cartilage degradation, in septic 
). 
a KLS = 4. Reported are the C2C levels relative to the total protein 
content. 
� �  =  0.34  �  =   0.001 
IL-1� 
�  = 0.049 
� 
articular concentrations of IL-1� 
�  =  0.42  �  < 0.001 
arthritis (� < 0.001). All protein levels were analyzed relative to the 
� 
� 
� = 0.16 
for C 
e subgroup of septic knee  arthritis. 
The same association was further calculated based on the 
 
1� levels. The �-test, defining statistical significance for the concentrations of bFGF, BMP-2, and BMP-7 with rising IL- 
Re
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M
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Increased blood leucocyte counts correlate with 
intra-articular collagen type II degradation 
20 
p < 0.001 
 
15 
 
 
10 
 
 
5 
Levels of collagen cleavage products increase 
with preexisting degradation in infected knees 
10 
 
9 
 
8 
 
7 
 
6 
 
0 
Normal 
 
 
Leucocyte counts 
 
Increased 
5 
0 1 2 3 
Kellgren Lawrence score 
All, n = 76, pcorrelation < 0.01 
Knee, n = 57, pcorrelation < 0.01 
C2C, pcorrelation < 0.05, pH-test n.s. 
Figure 2: An increasing Kellgren Lawrence Score (KLS), defining 
 
a cartilage breakdown product. This reached statistical significance knee arthritis (� = 0.049 The group KLS 3 includes one case with 
 
 
 
There was also a positive correlation of C2C concentrations 
with intra-articular IL-1 
 
 
0.08 
 
Synovial BMP-2, BMP-7, and bFGF level increase 
with IL-1� concentrations in infected knees 
 
 
0.6 
levels ( , ), 
which also characterize synovial inflammation. This could be 
confirmed in the subgroup of knee infections. An increasing 
Kellgren Lawrence Score (KLS), which radiologically defines 
the progress of osteoarthritis (OA), was associated with 
enhanced C2C levels in septic knee arthritis ( , 
Figure 2). The distribution of KLS was 18.0% grade 0, 34.4% 
grade 1, 27.9% grade 2, 18.0% grade 3, and 1.6% grade 4. OA 
was considered as a preinfectious joint damage, which was 
associated with a higher degree of inflammation (synovial 
concentrations). Although the regulation pattern was 
similar for aggrecan, the values failed to reach  statistical 
significance. 
3.5. Correlation of Proinflammatory IL-1  with the Mediators 
 
0.06 
 
0.04 
 
0.02 
 
0 
 
 
 
 
 
 
 
 
Relative IL-1� expression 
BMP-7, pcorrelation < 0.001, pH-test = 0.03 
bFGF, pcorrelation < 0.001, pH-test n.s. 
BMP-2, pcorrelation < 0.01, pH-test n.s. 
0.5 
0.4 
0.3 
0.2 
0.1 
0 
of Cartilage Metabolism bFGF, CD105, BMP-2, and  BMP- 
7  and  the  Anti-Inflammatory  Marker  IL-10.  Since intra- 
characterized the clinical 
relevance and severity of septic arthritis, the correlations 
to cytokines with known roles in chondrocyte anabolism 
or catabolism were analyzed, searching for the interaction 
between inflammation and cartilage metabolism.    Whereas 
 
 
Figure 3: Increased synovial IL-1 levels were associated with 
enhanced bFGF, BMP-2, and BMP-7 concentrations in septic knee 
synovial total protein content. 
 
cluster differences, was statistically significant only in case of 
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�
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influence of the bacteria species on the inflammatory reaction 
and cartilage destruction 3 groups were defined: no detection 
 3.6. Influence of Bacterial Strain. In order to analyze  the 
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p < 0.05 p < 0.05 
� 
pattern was observed for IL-10, showing the highest levels in the group following infections with other bacteria. (c) The expression pattern 
for C2C, indicating cartilage
−
d
6
estruction, is similar to IL-10, showing the highest levels in the group following infections with other bacteria. 
10 
highest levels in the group following infections with other bacteria. The significance levels indicated represent the ANOVA. no: no detection 
of bacteria; other: infections with other bacteria; Staph. species: infections with Staphylococcus species. 
expression of IL-1� (Figure 4(a)). An ANOVA was used as 
� < 0.001 
2, �  =  23), and other bacteria species (group 3, �  =  9). 
� = 44 
this for groups 1 and 3 (� = 0.02 d 0.024, resp.). There were 
� = 0.02 
The study’s main findings are that synovial IL-1� 
 
 
 
 
0.12 
 
0.1 
 
0.08 
 
0.06 
Synovial IL-1� expression depends on causing bacteria strain 
p < 0.05 
 
 
 
0.008 
 
 
0.006 
 
 
0.004 
Synovial IL-10 expression depends on causing bacteria strain 
n.s. 
 
0.04 
 
0.02 
 
0 
No Other 
 
 
 
 
Staph. species 
 
0.002 
 
 
0 
 
 
 
 
No Other Staph. species 
Identified bacteria species 
(a) 
Synovial C2C levels depend on causing bacteria strain 
n.s. 
 
80 
 
 
60 
 
 
40 
 
 
20 
 
 
0 
No Other Staph. species 
Identified bacteria species 
Identified bacteria species 
(b) 
Synovial aggrecan levels depend on causing bacteria strain 
n.s. 
 
80 
 
 
60 
 
 
40 
 
 
20 
 
 
0 
No Other Staph. species 
Identified bacteria species 
(c) (d) 
Figure 4: (a) The highest synovial IL-1 levels were observed following infections with Staphylococcus species. (b) A different expression 
Results represent values × . (d) The expression pattern for another cartilage breakdown marker, aggrecan, is similar to C2C, showing the 
 
 
 
of bacteria (group 1, ), Staphylococcus species (group 
Infections with Staphylococcus species induced the highest 
a screening test, showing statistically significant differences 
only between group 1 (no) and group 2 (Staph. species), 
which was confirmed by the direct comparison ( ). 
 
 
breakdown, demonstrated the same associations as IL-10, 
showing the highest concentration after infections with other 
bacterial strains (group 3). Although the ANOVA showed 
again statistically significant differences between group 3 and 
both other groups, the direct comparison could only confirm 
an 
no differences for the expression of CD105, bFGF, BMP-2, and 
The anti-inflammatory IL-10 showed a different regulatory 
pattern with highest levels in the group with other bacteria 
(Figure 4(b)). Although the ANOVA showed statistically sig- 
nificant differences between group 3 and both other groups, 
the direct comparison could only confirm this for groups 1 
and 3 ( ). C2C and aggrecan, both indicating cartilage 
BMP-7 between the groups. 
 
4. Discussion 
levels appear 
to be a reliable tool to measure the severity and clinical 
n.s. 
n.s. 
p < 0.05 p < 0.05 
p < 0.05 p < 0.05 
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of the proinflammatory markers TNF�, IL-1�, and IL-6 are 
was � 
articular IL-1� 
� 
� 
 
relevance of septic arthritis. Collagen type II cleavage prod- 
ucts (C2C) characterize cartilage degradation during acute 
joint infection better than other matrix breakdown products. 
Moreover, there is a positive correlation of the degree of intra- 
articular inflammation with upregulation of bFGF, BMP-2, 
and BMP-7, representing markers of cartilage metabolism. 
Regulation of inflammation and cartilage destruction are 
specifically associated with certain types of bacteria. 
Bacterial septic arthritis is frequently found in patients 
with a high comorbidity, can lead to joint destruction, and 
is associated with a high mortality. Synovial  concentrations 
elevated in the course of disease, in which TNF a 
cartilage metabolism could now be confirmed presenting this 
biomarker analysis and may explain the deleterious long- 
term effects of acute inflammation on the joint integrity. Pre- 
viously, upregulation of both proinflammatory cytokines and 
cartilage metabolites has been shown in vivo following LPS- 
stimulation of mononuclear cells [4]. In this study not only 
inflammatory cells but also chondrocytes and synoviocytes 
have actively contributed to the development of inflamma- 
tion. In fact, the prolonged effects of synoviocyte activation 
have been hallmarked as a reason for prolonged devastating 
cartilage effects after elimination of bacteria in other studies 
[20]. Our data indicate that joints with a preexisting intra- 
articular damage are more susceptible to inflammation. This 
better indicator to discriminate bacterial arthritis from other 
inflammatory arthritis [9]. The clinical relevance of intra- 
levels could be confirmed by our data, showing 
an association with systemic inflammatory parameters as 
serum leucocyte counts and serum CRP-levels. This   has 
patients undergoing surgical cartilage regenerating    proce- 
is in line with results showing an anti-inflammatory effect of 
cartilage itself leading to FAS ligand mediated protection of 
synovial fibroblasts [5]. Therefore, cartilage is not only target 
but also an attenuating effector in synovial inflammation. 
One advantage of in vitro studies is that they can describe 
indicate early upregulation of IL-1  and a delayed increase of 
dures [10]. Furthermore, elevated synovial IL-1�  vels were BMP-7 levels. Therefore, these cytokines represent initiation been demonstrated before in the postoperative follow-up of 
le 
more frequently found in patients with necessity of intensive 
care or in-hospital treatment and clinical empyema signs. In 
contrast, this could not be shown for patients with clinical 
sepsis signs. This indicates that sepsis in general seems to be 
associated with physical conditions beyond joint infection. 
Comorbidity, for example, associated with drug abuse or 
immunosuppression, which was not decisive in the course of 
cell-specific and time-dependent regulation patterns, which 
 
of inflammation and a secondary, postponed start of a 
regenerative phase. The results of our study support the idea 
that cytokine regulation during septic arthritis is specific 
for different strains of bacteria. This has been shown, for 
example, in Corynebacterium ulcerans infections [21]. These 
bacteria have a nonarthritogenic strain (BR-AD22). With 
regard to statistical necessities, the infectious bacteria in this 
 
The phenomena of synovial inflammation and  cartilage 
des 
1� ression, but less cartilage destruction. The mechanisms 
joint infection, seems to play a more important role in these 
patients [11]. 
truction occur within the same time frame as shown by the 
parallel upregulation of inflammatory cytokines and break- 
down products of the extracellular matrix. This was found 
in different studies investigating osteoarthritis [12], psoriatic 
arthritis [13], and trauma [14] in humans, and different other 
conditions including septic arthritis in animals [15]. Our data 
indicate that collagen type 2 cleavage products (C2C), which 
possess pharmacodynamic and physiological relevance for 
cartilage degradation [16], are a more reliable parameter char- 
acterizing cartilage degradation in septic arthritis compared 
to aggrecan. However, the levels of this matrix component 
were closely related to the development of osteoarthritis with- 
out acute infection [17]. The interactions between bacterial 
infection, upregulation of IL-1 and IL-6, chondrocyte apop- 
tosis, and cartilage degradation have been earlier described in 
vitro; however, the analysis of the molecular basis of the inter- 
action of proinflammatory parameters, matrix degradation, 
and cartilage metabolism in a human clinical trial was miss- 
ing. On the other hand, the potential benefits of IL-1 inhibi- 
tion applying IL-1 receptor-antagonist have been highlighted 
in a clinical trial attenuating the posttraumatic inflammation 
[18]. Furthermore, there are several studies investigating 
the possible beneficial effect for corticosteroids in septic 
arthritis showing promising data, but—similar to what is seen 
for specific inhibition of inflammatory mediators—current 
studies do not provide evidence of higher level for treatment 
efficacy [19]. The hypothesis that there is a relation of acute 
bacterial inflammation and cartilage degradation as well as 
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trial were summarized in groups, showing that 
inflammation 
caused by Staphylococcus species is associated with a high IL- 
exp 
behind this effect cannot be clarified based on this observa- 
tional study. 
Although the time of analysis was defined and 
prospec- tively correlated with clinical signs of 
inflammation, we only present values of a single sample 
without time courses. This cross-sectional character of the 
presented analysis certainly limits the interpretation of 
the results. Furthermore, it is an observational study, 
which does not allow drawing conclu- sions with regard 
to biochemical or physiological interac- tions. 
Furthermore, typical limitations of a clinical study have to 
be taken into account. This includes the limited number 
and a high diversity of the examined patient 
population. The ASA classification is a reliable 
instrument to classify the health status but does not 
evaluate different metabolic elimination characteristics, 
for example, seen in kidney or liver failure, which 
possibly also exhibits an influence on the concentrations of 
the measured cytokines. 
In conclusion, articular infection and synovial 
inflamma- tion are bacteria-specific and have direct 
influence on carti- lage metabolism. Collagen type II 
cleavage products reliably mark destruction, which is 
associated with upregulation of typical cartilage 
turnover cytokines as bFGF, BMP-2, and BMP-7. 
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